346
IRUS TotalDownloads
Altmetric
O-RADS US risk stratification and management system: A consensus guideline from the ACR ovarian-adnexal reporting and data system committee.
File | Description | Size | Format | |
---|---|---|---|---|
![]() | Published version | 9.1 MB | Adobe PDF | View/Open |
Title: | O-RADS US risk stratification and management system: A consensus guideline from the ACR ovarian-adnexal reporting and data system committee. |
Authors: | Andreotti, RF Timmerman, D Strachowski, LM Froyman, W Benacerraf, BR Bennett, GL Bourne, T Brown, DL Coleman, BG Frates, MC Goldstein, SR Hamper, UM Horrow, MM Hernanz-Schulman, M Reinhold, C Rose, SL Whitcomb, BP Wolfman, WL Glanc, P |
Item Type: | Journal Article |
Abstract: | The Ovarian-Adnexal Reporting and Data System (O-RADS) US risk stratification and management system is designed to provide consistent interpretations, to decrease or eliminate ambiguity in US reports resulting in a higher probability of accuracy in assigning risk of malignancy to ovarian and other adnexal masses, and to provide a management recommendation for each risk category. It was developed by an international multidisciplinary committee sponsored by the American College of Radiology and applies the standardized reporting tool for US based on the 2018 published lexicon of the O-RADS US working group. For risk stratification, the O-RADS US system recommends six categories (O-RADS 0-5), incorporating the range of normal to high risk of malignancy. This unique system represents a collaboration between the pattern-based approach commonly used in North America and the widely used, European-based, algorithmic-style International Ovarian Tumor Analysis (IOTA) Assessment of Different Neoplasias in the Adnexa model system, a risk prediction model that has undergone successful prospective and external validation. The pattern approach relies on a subgroup of the most predictive descriptors in the lexicon based on a retrospective review of evidence prospectively obtained in the IOTA phase 1-3 prospective studies and other supporting studies that assist in differentiating management schemes in a variety of almost certainly benign lesions. With O-RADS US working group consensus, guidelines for management in the different risk categories are proposed. Both systems have been stratified to reach the same risk categories and management strategies regardless of which is initially used. At this time, O-RADS US is the only lexicon and classification system that encompasses all risk categories with their associated management schemes. |
Issue Date: | Jan-2020 |
Date of Acceptance: | 12-Sep-2019 |
URI: | http://hdl.handle.net/10044/1/75373 |
DOI: | 10.1148/radiol.2019191150 |
ISSN: | 0033-8419 |
Publisher: | Radiological Society of North America |
Start Page: | 168 |
End Page: | 185 |
Journal / Book Title: | Radiology |
Volume: | 294 |
Issue: | 1 |
Copyright Statement: | ©RSNA, 2019. This manuscript is licensed under the Creative Commons Attribution Non-Commercial Licence 4.0 International ( https://creativecommons.org/licenses/by-nc/4.0/ ). |
Keywords: | Science & Technology Life Sciences & Biomedicine Radiology, Nuclear Medicine & Medical Imaging UK COLLABORATIVE TRIAL SONOGRAPHIC FINDINGS EXTERNAL VALIDATION TRANSVAGINAL SONOGRAPHY MATHEMATICAL-MODELS CLINICAL-PRACTICE CYSTIC TERATOMAS LIKELIHOOD RATIO PELVIC MASSES CANCER 11 Medical and Health Sciences Nuclear Medicine & Medical Imaging |
Publication Status: | Published |
Conference Place: | United States |
Online Publication Date: | 2019-11-05 |
Appears in Collections: | Department of Metabolism, Digestion and Reproduction |